Kelsopharma.com

United Kingdom Founded: 2020 • Age: 6 yrs
RD company focused on manufacturing of drugs for multiple therapeutic areas
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors - Brand Intelligence

About Kelsopharma.com

Kelsopharma.com is a company based in United Kingdom founded in 2020. Kelsopharma.com has completed 3 acquisitions, including Alturix, Stirling Anglian Pharmaceuticals and Velit Biopharma. Kelsopharma.com offers products and services including Branded Medicines.

  • Headquarter United Kingdom
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Kelso Pharma Limited
  • Date of Incorporation 20 Oct, 2020
  • Jurisdiction KELSO, UNITED KINGDOM
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
  • Investments & Acquisitions
    Alturix

    & 2 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Kelsopharma.com

Kelsopharma.com offers a comprehensive portfolio of products and services, including Branded Medicines.

Product name locked
Category locked
Primary

Offers specialty medicines that enhance patient compliance and affordability.

Funding Insights of Kelsopharma.com

Premium access

Detailed funding history for Kelsopharma.com

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Kelsopharma.com

Kelsopharma.com has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Alturix, Stirling Anglian Pharmaceuticals and Velit Biopharma.

Investments
Premium access

Investment portfolio details for Kelsopharma.com

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Pharmaceutical company that specializes in the development, distributing, and manufacturing of bio and nano pharmaceuticals, medical devices, and food supplements
Locked Locked 2018 Locked
Manufacturer of anti inflammatory & constipation drugs
Locked Locked 2013 Locked
-
Locked Locked 0 Locked
Premium access

Complete acquisition details for Kelsopharma.com

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Kelsopharma.com

Premium access

Detailed financials for Kelsopharma.com

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Kelsopharma.Com Comparisons

Kelsopharma.com Primary company
Description
R&D company focused on manufacturing of drugs for multiple t...
Location
United Kingdom
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Kelsopharma.com

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Kelsopharma.com

Premium access

Detailed competitors of Kelsopharma.com

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Kelsopharma.Com

Premium access

Complete news archive for Kelsopharma.com

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kelsopharma.com

Kelsopharma.com was founded in 2020.

Kelsopharma.com is headquartered in United Kingdom.

Thomas Stratford is the current CEO of Kelsopharma.com.

Kelsopharma.com rd company focused on manufacturing of drugs for multiple therapeutic areas, focusing on providing healthcare solutions, and diversified pharmaceuticals. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

Kelsopharma.com offers Branded Medicines.

Kelsopharma.com has made 3 acquisitions, including Alturix, Stirling Anglian Pharmaceuticals, and Velit Biopharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available